Michael M. Wick
2011
In 2011, Michael M. Wick earned a total compensation of $788.3K as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 53% increase compared to previous year.
Compensation breakdown
| Option Awards | $274,300 |
|---|---|
| Salary | $514,000 |
| Total | $788,300 |
Wick received $514K in salary, accounting for 65% of the total pay in 2011.
Wick also received $274.3K in option awards.
Rankings
In 2011, Michael M. Wick's compensation ranked 6,518th out of 10,747 executives tracked by ExecPay. In other words, Wick earned more than 39.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,518 out of 10,747 | 39th |
Division Manufacturing | 2,363 out of 3,960 | 40th |
Major group Chemicals And Allied Products | 551 out of 1,033 | 47th |
Industry group Drugs | 362 out of 781 | 54th |
Industry Pharmaceutical Preparations | 287 out of 571 | 50th |
Source: SEC filing on April 5, 2013.
Wick's colleagues
We found four more compensation records of executives who worked with Michael M. Wick at MabVax Therapeutics Holdings in 2011.
2011
Marc Steuer
MabVax Therapeutics Holdings
Former Senior Vice President, Business Development
2011
Wendy Wee
MabVax Therapeutics Holdings
Vice President, Finance and Controller
2011
Steven Schow
MabVax Therapeutics Holdings
Vice President, Research
2011
William Kaplan
MabVax Therapeutics Holdings